The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
Baseline cognitive tests identified individuals with all-cause MCI in the UK Biobank.We compared individuals with MCI to propensity score-matched participants without MCI.Inpatient costs were 7.6% higher over 10 years, and primary care costs were 9.1% higher over 6 years for participants with MCI.AD dementia incidence rate ratio was 7.2 higher in participants with MCI.Among MCI participants, eventual AD dementia was a key driver of costs resulting in higher inpatient costs (mean £20,199) over 10 years.
Authors
- Julie Hahn-Pedersen (ORCID: https://orcid.org/0000-0001-8187-7047)
- Benjamin Bray (ORCID: https://orcid.org/0000-0002-8983-7530)
- Craig Ritchie (ORCID: https://orcid.org/0000-0002-6202-6906)
- Marc Evans (ORCID: https://orcid.org/0000-0003-0671-0778)
- Dominic Trépel (ORCID: https://orcid.org/0000-0002-1421-2966)
- A. J. Clark (ORCID: https://orcid.org/0000-0003-1369-8017)
- Sophie Edwards
- Christian Ahmad Wichmann
- Mei Sum Chan
Institutions
- University of St Andrews (GB)
- Novo Nordisk (Denmark) (DK)
- Trinity College Dublin (IE)
- Barts Health NHS Trust (GB)
- University Hospital Llandough (GB)
Publication Details
- Journal
- Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/dad2.70065
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Novo Nordisk